Van Eck Associates Corp Adma Biologics, Inc. Transaction History
Van Eck Associates Corp
- $78.1 Billion
- Q4 2024
A detailed history of Van Eck Associates Corp transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Van Eck Associates Corp holds 199,630 shares of ADMA stock, worth $3.73 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
199,630Holding current value
$3.73 Million% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ADMA
# of Institutions
339Shares Held
182MCall Options Held
1.72MPut Options Held
846K-
Black Rock Inc. New York, NY18.6MShares$348 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$340 Million0.01% of portfolio
-
State Street Corp Boston, MA14.9MShares$278 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA11.3MShares$211 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.53MShares$103 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.67B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...